Hyperactive immune resistance brings blindness in old age

An Anglo-German research team embracing immunologists from Göttingen University has added a further important aspect to our current knowledge of the processes leading to senile blindness. For the first time, they have been able to show that in the case of patients with AMD their entire immune system is hyperactive. It had not previously been known whether such an immune reaction affecting the entire body played any role in this eye disease.

The investigation was conducted by scientists from Bonn, Göttingen, Regensburg and Oxford under the leadership of Privatdozent Dr. Hendrik Scholl of Bonn University´s Eye Clinic. The results achieved by this research team have now been published in the current edition of the PLoS ONE:
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0002593

Faults in the (immune) System

The Anglo-German research team worked on the hypothesis that one cause of the appearance of senile blindness, AMD, might be faulty regulation of the so-called complement system. This system is an important element in our hereditary immune resistance, and is involved where inflammatory reactions occur. Previously, it had only been known that changes in genes containing the hereditary information for proteins in the complement system increase the risk of contracting AMD. Some of these proteins activate, others inhibit, the complement system.

The team examined the blood of a total of 112 AMD-patients and 67 healthy control persons for signs of faults in the regulation of their complement systems. They sought out changes in protein concentration which would indicate activation of the complement system. The experiments were conducted in Göttingen University´s Department for Cellular and Molecular Immunology under the leadership of Professor Dr. Martin Oppermann. The investigations of the patients´ blood did, indeed, reveal clear changes in the concentrations of a number of complement proteins which, moreover, correlated closely to the previously identified hereditary factors.

Dormant inflammatory Situation of the Body

"Our study has revealed for the first time that in the case of AMD patients the complement system is hyperactive over the entire body", Dr. Hendrik Scholl declares. The typical substances indicating a permanent inflammatory reaction circulate in the blood. "These results infer that senile blindness may arise from a permanent state of inflammation in the body. This can obviously lie dormant for decades, then in advanced old age can lead to the appearance of symptoms of the disease. According to Dr. Scholl, the point of most acute vision, at the centre of the retina, appears to be the susceptible point.

In Germany, an estimated 4.5 million people suffer from age-dependent macular degeneration (AMD). With this disease, the point of most acute vision on the retina (macula) becomes subject to progressive deterioration. The patient can no longer read, and he or she loses the ability to lead an independent existence. Opthalmologists had hitherto known comparatively little about the causes of this disease, except that hereditary factors were involved, and also other easily influenced factors, such as smoking.

Source: University of Bonn

Genetic finding implicates innate immune system in major cause of blindness
Scientists have identified one of the genes implicated in age-related macular degeneration, the most common cause of blindness in developed countries.
Gene variant increases risk of blindness
Researchers have found a gene variant that can more than double the risk of developing the degenerative eye disease, age-related macular degeneration.
Flu deaths could be reduced thanks to cancer research
(PhysOrg.com) -- Cells involved in the body’s immune response to cancer are also implicated in influenza infection and could be targeted in new flu vaccination strategies, scientists at Oxford University have discovered.
NASA Maps Shed Light on Carbon Dioxide's Global Nature
(PhysOrg.com) -- A NASA/university team has published the first global satellite maps of the key greenhouse gas carbon dioxide in Earth's mid-troposphere, an area about 8 kilometers, or 5 miles, above Earth. The team's study reveals new information on how carbon dioxide, which directly contributes to climate change, is distributed in Earth's atmosphere and moves around our world.
Study shows immune system can hurt as well as help fight cancer
Researchers at the University of Pennsylvania School of Medicine have found that some proteins of the immune system can promote tumor growth. Investigators found that instead of fighting tumors, the protein C5a, which is produced during an immune response to a developing tumor, helps tumors build molecular shields against T-cell attack. These findings appeared online this week in Nature Immunology.
New discovery may lead to immunization against cardiovascular disease
Low levels of naturally occurring antibodies may represent an increased risk of developing cardiovascular disease, particularly stroke in men. This discovery, published in the academic journal Atherosclerosis, has now led to attempts to develop an immunization against cardiovascular disease.
Common cooking spice shows promise in combating diabetes and obesity
Shown to reverse inflammation associated with obesity and improves blood sugar control
Turmeric, an Asian spice found in many curries, has a long history of use in reducing inflammation, healing wounds and relieving pain, but can it prevent diabetes? Since inflammation plays a big role in many diseases and is believed to be involved in onset of both obesity and Type 2 diabetes, Drew Tortoriello, M.D., an endocrinologist and research scientist at the Naomi Berrie Diabetes Center at Columbia University Medical Center, and his colleagues were curious what effect the herb might have on diabetic mice.
NIAMS scientists find potential new way to block inflammation in autoimmune disease
Researchers from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health (NIH), have identified a promising new target for autoimmune disease treatment – a cell-surface receptor called DR3. Their research in mice, published on line in the journal Immunity, suggests that blocking this receptor could slow or stop the damaging inflammation characteristic of autoimmune diseases, potentially without leaving the body vulnerable to serious infections, as many current therapies do.

Hyperactive immune resistance brings blindness in old age

Related stories:

News discussion: